Based on the Brickell Biotech Inc stock forecast from 0 analysts, the average analyst target price for Brickell Biotech Inc is not available over the next 12 months. Brickell Biotech Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Brickell Biotech Inc is Neutral, which is based on 7 positive signals and 7 negative signals. At the last closing, Brickell Biotech Inc’s stock price was USD 0.82. Brickell Biotech Inc’s stock price has changed by +4.47% over the past week, -7.67% over the past month and -55.43% over the last year.
No recent analyst target price found for Brickell Biotech Inc
No recent average analyst rating found for Brickell Biotech Inc
Company Overview Brickell Biotech Inc
BBI Bürgerliches Brauhaus Immobilien AG operates as a real estate company in Germany. The company engages in the acquisition, rental, and management of retail properties. Its portfolio includes shopping centers and retail parks. The company is headquartered in Ingolstadt, Germany. BBI Bürgerliches Brauhaus Immobilien AG is a subsidiary of VIB Vermögen AG. Read Less
BBI Bürgerliches Brauhaus Immobilien AG operates as a real estate company in Germany. The company engages in the acquisition, rental, and management of retail properties. Its portfolio includes shopping centers and retail parks. The company is headquartered in Ingolstadt, German...Read More
Frequently Asked Questions About Brickell Biotech Inc (BBI) Stock
Stock Target Advisor's fundamental analysis for Brickell Biotech Inc's stock is Neutral.
BBI stock's dividend yield is 6.87%.
Our analysis grades BBI stock's dividend yield at C+. This means that BBI stock's dividend yield is above 79% of the stocks in the Real Estate Services sector in the NSD exchange.
Based on this BBI may be a average dividend stock for its sector.
Unfortunately we do not have enough data on BBI's stock to indicate what its average analyst target is.
BBI stock's Price/Earning ratio is 0.56.
Our analysis grades BBI stock's Price / Earning ratio at A-. This means that BBI stock's Price/Earning ratio is above 8.999999999999996% of the stocks in the Real Estate Services sector in the NSD exchange.
Based on this BBI may be undervalued for its sector.
The last closing price of BBI's stock was USD 0.82.
The most recent market capitalization for BBI is USD 0.05B.
Unfortunately we do not have enough analyst data on BBI's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Brickell Biotech Inc's stock.
As per our most recent records Brickell Biotech Inc has 0 Employees.
Brickell Biotech Inc's registered address is Manchinger Str. 95, Ingolstadt, Germany, 85053.
You can get more information about it from Brickell Biotech Inc's website at https://www.bbi-immobilien-ag.de.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BBI !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
